Katja Nitschke

649 total citations
36 papers, 437 citations indexed

About

Katja Nitschke is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Katja Nitschke has authored 36 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 15 papers in Cancer Research and 10 papers in Oncology. Recurrent topics in Katja Nitschke's work include Extracellular vesicles in disease (8 papers), Bladder and Urothelial Cancer Treatments (8 papers) and MicroRNA in disease regulation (7 papers). Katja Nitschke is often cited by papers focused on Extracellular vesicles in disease (8 papers), Bladder and Urothelial Cancer Treatments (8 papers) and MicroRNA in disease regulation (7 papers). Katja Nitschke collaborates with scholars based in Germany, United Kingdom and United States. Katja Nitschke's co-authors include Thomas Stefan Worst, Philipp Erben, Robert Thimme, Christoph Neumann‐Haefelin, Štefan Porubský, Philipp Nuhn, Karen Bieback, Markus Eckstein, Jost von Hardenberg and Cleo‐Aron Weis and has published in prestigious journals such as Hepatology, Journal of Virology and Scientific Reports.

In The Last Decade

Katja Nitschke

34 papers receiving 431 citations

Peers

Katja Nitschke
Mingli Gu China
Jia Fan China
Tine S. Mantoni United Kingdom
Xiaowu Li China
Xile Zhou China
Mingli Gu China
Katja Nitschke
Citations per year, relative to Katja Nitschke Katja Nitschke (= 1×) peers Mingli Gu

Countries citing papers authored by Katja Nitschke

Since Specialization
Citations

This map shows the geographic impact of Katja Nitschke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katja Nitschke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katja Nitschke more than expected).

Fields of papers citing papers by Katja Nitschke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katja Nitschke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katja Nitschke. The network helps show where Katja Nitschke may publish in the future.

Co-authorship network of co-authors of Katja Nitschke

This figure shows the co-authorship network connecting the top 25 collaborators of Katja Nitschke. A scholar is included among the top collaborators of Katja Nitschke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katja Nitschke. Katja Nitschke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Walach, Margarete Teresa, Katja Nitschke, Frederik Wessels, et al.. (2025). Prognostic scores for predicting overall survival in patients with metastatic renal and urothelial cancer undergoing immunotherapy - which one to use?. World Journal of Urology. 43(1). 93–93.
2.
Bieback, Karen, Stefanie Uhlig, Marie‐Nicole Theodoraki, et al.. (2024). Optimization of extracellular vesicles preparation from saliva of head and neck cancer patients. Scientific Reports. 14(1). 946–946. 6 indexed citations
3.
Schneider, Martin, et al.. (2024). Optimized workflow of EV enrichment from human plasma samples for downstream mass spectrometry analysis. Discover Oncology. 15(1). 374–374. 1 indexed citations
4.
Popović, Zoran V., Fabian Siegel, Maurice Stephan Michel, et al.. (2024). Prognostic significance of EGFR, AREG and EREG amplification and gene expression in muscle invasive bladder cancer. Frontiers in Oncology. 14. 1370303–1370303. 1 indexed citations
5.
Li, Hui, Annette Breedijk, Nadine Dietrich, et al.. (2023). Lipopolysaccharide Tolerance in Human Primary Monocytes and Polarized Macrophages. International Journal of Molecular Sciences. 24(15). 12196–12196. 6 indexed citations
6.
Jabłońska, Jadwiga, Marie‐Nicole Theodoraki, Katja Nitschke, et al.. (2023). Plasma-derived small extracellular vesicles unleash the angiogenic potential in head and neck cancer patients. Molecular Medicine. 29(1). 69–69. 7 indexed citations
7.
Neuberger, Manuel, Christel Weiß, Frederik Wessels, et al.. (2022). Systemic inflammatory biomarkers as predictive and prognostic factors in men with metastatic castration-refractory prostate cancer treated with docetaxel therapy: a comprehensive analysis in a German real-world cohort. Journal of Cancer Research and Clinical Oncology. 149(7). 3371–3381. 9 indexed citations
8.
Neuberger, Manuel, Christel Weiß, Katja Nitschke, et al.. (2022). Changes in neutrophile-to-lymphocyte ratio as predictive and prognostic biomarker in metastatic prostate cancer treated with taxane-based chemotherapy. Discover Oncology. 13(1). 140–140. 2 indexed citations
9.
Schmidt, Helena, Katja Nitschke, Cleo‐Aron Weis, et al.. (2021). RNA Expression of DNA Damage Response Genes in Muscle-Invasive Bladder Cancer: Influence on Outcome and Response to Adjuvant Cisplatin-Based Chemotherapy. International Journal of Molecular Sciences. 22(8). 4188–4188. 5 indexed citations
10.
Costina, Victor, et al.. (2021). Coupling size exclusion chromatography to ultracentrifugation improves detection of exosomal proteins from human plasma by LC-MS. Practical Laboratory Medicine. 26. e00241–e00241. 21 indexed citations
11.
Nitschke, Katja, Jost von Hardenberg, Philipp Nuhn, et al.. (2020). Phosphodiesterase SMPDL3B Gene Expression as Independent Outcome Prediction Marker in Localized Prostate Cancer. International Journal of Molecular Sciences. 21(12). 4373–4373. 6 indexed citations
12.
Müller, Kilian J., Katja Nitschke, Philipp Erben, et al.. (2020). B-MYB—p53-related relevant regulator for the progression of clear cell renal cell carcinoma. Journal of Cancer Research and Clinical Oncology. 147(1). 129–138. 5 indexed citations
13.
Crigna, Adriana Torres, Fabia Fricke, Katja Nitschke, et al.. (2020). Inter-Laboratory Comparison of Extracellular Vesicle Isolation Based on Ultracentrifugation. Transfusion Medicine and Hemotherapy. 48(1). 48–59. 40 indexed citations
14.
Nitschke, Katja, Philipp Erben, Cleo‐Aron Weis, et al.. (2019). Clinical relevance of gene expression in localized and metastatic prostate cancer exemplified by FABP5. World Journal of Urology. 38(3). 637–645. 15 indexed citations
15.
Worst, Thomas Stefan, Christopher Previti, Katja Nitschke, et al.. (2019). miR-10a-5p and miR-29b-3p as Extracellular Vesicle-Associated Prostate Cancer Detection Markers. Cancers. 12(1). 43–43. 58 indexed citations
16.
Wu, Sheng, Katja Nitschke, Cleo‐Aron Weis, et al.. (2019). ANLN and TLE2 in Muscle Invasive Bladder Cancer: A Functional and Clinical Evaluation Based on In Silico and In Vitro Data. Cancers. 11(12). 1840–1840. 17 indexed citations
17.
Hardenberg, Jost von, Sarah Hartmann, Katja Nitschke, et al.. (2018). Programmed Death Ligand 1 (PD-L1) Status and Tumor-Infiltrating Lymphocytes in Hot Spots of Primary and Liver Metastases in Prostate Cancer With Neuroendocrine Differentiation. Clinical Genitourinary Cancer. 17(2). 145–153.e5. 8 indexed citations
18.
Esser‐Nobis, Katharina, Julia Schmidt, Katja Nitschke, et al.. (2016). The cyclophilin-inhibitor alisporivir stimulates antigen presentation thereby promoting antigen-specific CD8+ T cell activation. Journal of Hepatology. 64(6). 1305–1314. 5 indexed citations
19.
Ashraf, Shirin, Katja Nitschke, U. Warshow, et al.. (2013). Synergism of Tapasin And Human Leukocyte Antigens in Resolving Hepatitis C Virus Infection. Hepatology. 58(3). 881–889. 15 indexed citations
20.
Thiele, Karl‐Heinz, et al.. (2008). Population data of eight X-chromosomal STR markers in Ewe individuals from Ghana. Forensic science international. Genetics supplement series. 1(1). 167–169. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026